Haemonetics (HAE) Competitors $76.26 -0.06 (-0.08%) Closing price 07/2/2025 03:59 PM EasternExtended Trading$76.55 +0.29 (+0.39%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HAE vs. ALGN, MMSI, ICUI, XRAY, QDEL, NEOG, STAA, CERS, OSUR, and UTMDShould you be buying Haemonetics stock or one of its competitors? The main competitors of Haemonetics include Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), and Utah Medical Products (UTMD). These companies are all part of the "health care supplies" industry. Haemonetics vs. Its Competitors Align Technology Merit Medical Systems ICU Medical DENTSPLY SIRONA QuidelOrtho Neogen STAAR Surgical Cerus OraSure Technologies Utah Medical Products Haemonetics (NYSE:HAE) and Align Technology (NASDAQ:ALGN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings. Which has stronger earnings & valuation, HAE or ALGN? Align Technology has higher revenue and earnings than Haemonetics. Haemonetics is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHaemonetics$1.36B2.69$167.68M$3.3123.04Align Technology$4.00B3.57$421.36M$5.4935.88 Is HAE or ALGN more profitable? Haemonetics has a net margin of 12.32% compared to Align Technology's net margin of 10.29%. Haemonetics' return on equity of 26.37% beat Align Technology's return on equity.Company Net Margins Return on Equity Return on Assets Haemonetics12.32% 26.37% 9.22% Align Technology 10.29%13.52%8.36% Do institutionals and insiders have more ownership in HAE or ALGN? 99.7% of Haemonetics shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 1.8% of Haemonetics shares are owned by insiders. Comparatively, 0.7% of Align Technology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more risk & volatility, HAE or ALGN? Haemonetics has a beta of 0.39, indicating that its share price is 61% less volatile than the S&P 500. Comparatively, Align Technology has a beta of 1.63, indicating that its share price is 63% more volatile than the S&P 500. Does the media favor HAE or ALGN? In the previous week, Align Technology had 7 more articles in the media than Haemonetics. MarketBeat recorded 20 mentions for Align Technology and 13 mentions for Haemonetics. Align Technology's average media sentiment score of 1.33 beat Haemonetics' score of 0.79 indicating that Align Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Haemonetics 5 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 14 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend HAE or ALGN? Haemonetics presently has a consensus target price of $96.80, indicating a potential upside of 26.93%. Align Technology has a consensus target price of $241.25, indicating a potential upside of 22.47%. Given Haemonetics' stronger consensus rating and higher probable upside, equities analysts clearly believe Haemonetics is more favorable than Align Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Haemonetics 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 2.91Align Technology 1 Sell rating(s) 4 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.67 SummaryAlign Technology beats Haemonetics on 9 of the 17 factors compared between the two stocks. Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HAE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HAE vs. The Competition Export to ExcelMetricHaemoneticsMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$3.67B$10.49B$5.54B$20.53BDividend YieldN/A2.09%5.39%3.77%P/E Ratio23.0416.6626.2327.85Price / Sales2.6929.93413.2337.49Price / Cash10.5922.7836.1321.91Price / Book4.673.648.044.55Net Income$167.68M$233.36M$3.15B$984.95M7 Day Performance1.94%1.00%1.44%2.31%1 Month Performance9.47%3.01%3.62%4.85%1 Year Performance-9.41%-11.64%34.68%13.81% Haemonetics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HAEHaemonetics4.8601 of 5 stars$76.26-0.1%$96.80+26.9%-8.2%$3.67B$1.36B23.042,820ALGNAlign Technology4.6232 of 5 stars$183.42+0.9%$241.25+31.5%-17.8%$13.30B$4.00B33.4120,945Positive NewsMMSIMerit Medical Systems4.3834 of 5 stars$92.32+0.4%$109.11+18.2%+8.1%$5.46B$1.36B45.267,400Positive NewsICUIICU Medical4.5976 of 5 stars$128.07+0.3%$192.67+50.4%+15.9%$3.15B$2.38B-33.4415,000News CoverageXRAYDENTSPLY SIRONA4.5177 of 5 stars$15.48+0.8%$20.36+31.5%-32.2%$3.09B$3.79B-3.4114,000Positive NewsQDELQuidelOrtho4.3614 of 5 stars$27.65-1.4%$44.33+60.3%-3.8%$1.87B$2.78B-5.566,600NEOGNeogen3.9909 of 5 stars$4.77-3.4%$9.00+88.7%-65.4%$1.04B$924.22M-2.142,110Analyst ForecastHigh Trading VolumeSTAASTAAR Surgical4.0306 of 5 stars$16.68+2.1%$24.63+47.6%-60.6%$826.16M$313.90M-11.581,211News CoverageCERSCerus3.1332 of 5 stars$1.34flat$3.50+161.2%-8.2%$256.15M$180.27M-13.40290Positive NewsOSUROraSure Technologies2.5339 of 5 stars$3.03+1.0%$3.00-1.0%-25.0%$226.64M$161.63M-7.21840Positive NewsUTMDUtah Medical Products2.6302 of 5 stars$54.89+2.3%N/A-13.0%$178.28M$39.27M14.52180News Coverage Related Companies and Tools Related Companies Align Technology Alternatives Merit Medical Systems Alternatives ICU Medical Alternatives DENTSPLY SIRONA Alternatives QuidelOrtho Alternatives Neogen Alternatives STAAR Surgical Alternatives Cerus Alternatives OraSure Technologies Alternatives Utah Medical Products Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HAE) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Haemonetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
